Phyllis Ira Spuls

Amsterdam UMC Location University of Amsterdam · Amsterdam University Medical Centers · Amsterdam Public Health

6本站收录论文

63这些论文的被引

4本站 h 指数

12合作者

作者编号 A5072786878 · ORCID 0000-0002-6035-2863。统计只算本站收录的论文。

发表的论文6 篇，按出版时间

1
Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseasesExpert Opinion on Drug Safety20236
2
Analysis and visualization of the course and burden over time of adverse drug reactions (ADRs) attributed to TNFα-inhibitors in patients with inflammatory rheumatic diseases (IRDs)Expert Opinion on Drug Safety20222
3
Barriers and facilitators for systematically registering adverse drug reactions in electronic health records: a qualitative study with Dutch healthcare professionalsExpert Opinion on Drug Safety202216
4
Patients’ perspectives on a drug safety monitoring system for immune-mediated inflammatory diseases based on patient-reported outcomesExpert Opinion on Drug Safety20214
5
Immune-mediated inflammatory disease patients’ preferences in adverse drug reaction information regarding biologicsExpert Opinion on Drug Safety20209
6
Patient-Reported Burden of Adverse Drug Reactions Attributed to Biologics Used for Immune-Mediated Inflammatory DiseasesDrug Safety202026

按月发文

逐年被引

合作者

Frank Hoentjen6 篇 Naomi T. Jessurun6 篇 Harald E. Vonkeman6 篇 Martijn B. A. van Doorn6 篇 Bart J. F. van den Bemt5 篇 Sander W. Tas5 篇 Michael Twahier Nurmohamed5 篇 Eugène van Puijenbroek4 篇 Leanne J. Kosse3 篇 Jette A. van Lint2 篇 Helen R. Gosselt2 篇 Gerda Weits2 篇

研究主题和期刊

Expert Opinion on Drug Safety5 Drug Safety1